Ranbaxy gets FDA approval for depression drug
That's Cricket - Washington: India's drug major Ranbaxy Laboratories has received the US Food and Drug Administration (FDA)'s final approval to manufacture and market its formulation for the treatment of major depressive disorders in adults. Ranbaxy Pharmaceuticals
Source: news.indiainfo.com
Click here for more information about manic depression manic depression
